Proteomics approaches for the studies of bone metabolism
暂无分享,去创建一个
[1] Yuan Cheng,et al. Comparative proteomics of glioma stem cells and differentiated tumor cells identifies S100A9 as a potential therapeutic target , 2013, Journal of cellular biochemistry.
[2] Kyu-Tae Chang,et al. Role of gangliosides in the differentiation of human mesenchymal-derived stem cells into osteoblasts and neuronal cells , 2013, BMB reports.
[3] B. Badran,et al. Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts. , 2013, World journal of stem cells.
[4] J. Eng,et al. Protein Kinase PKN1 Represses Wnt/β-Catenin Signaling in Human Melanoma Cells* , 2013, The Journal of Biological Chemistry.
[5] J. Foekens,et al. Quantitative proteomic analysis of microdissected breast cancer tissues: comparison of label-free and SILAC-based quantification with shotgun, directed, and targeted MS approaches. , 2013, Journal of proteome research.
[6] H. Ishikawa,et al. In vitro analysis of mesenchymal stem cells derived from human teeth and bone marrow , 2013, Odontology.
[7] Jeroen A. A. Demmers,et al. Activin A Suppresses Osteoblast Mineralization Capacity by Altering Extracellular Matrix (ECM) Composition and Impairing Matrix Vesicle (MV) Production* , 2013, Molecular & Cellular Proteomics.
[8] M. Masuda,et al. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine. , 2013, Japanese journal of clinical oncology.
[9] Kyong-Tai Kim,et al. Comparative secretome analysis of human bone marrow‐derived mesenchymal stem cells during osteogenesis , 2013, Journal of cellular physiology.
[10] A. Oberg,et al. Statistical methods for quantitative mass spectrometry proteomic experiments with labeling , 2012, BMC Bioinformatics.
[11] I. Kratchmarova,et al. Temporal Profiling and Pulsed SILAC Labeling Identify Novel Secreted Proteins During Ex Vivo Osteoblast Differentiation of Human Stromal Stem Cells* , 2012, Molecular & Cellular Proteomics.
[12] G. Rho,et al. In vitro and in vivo osteogenesis of human mesenchymal stem cells derived from skin, bone marrow and dental follicle tissues. , 2012, Differentiation; research in biological diversity.
[13] R. Moon,et al. Wnt/β-catenin pathway regulates bone morphogenetic protein (BMP2)-mediated differentiation of dental follicle cells. , 2012, Journal of periodontal research.
[14] Richard D. Smith,et al. Advancing the sensitivity of selected reaction monitoring‐based targeted quantitative proteomics , 2012, Proteomics.
[15] Jin Wang,et al. Smads, p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells. , 2012, BMB reports.
[16] O. Lee,et al. Phosphoproteomic analysis of human mesenchymal stromal cells during osteogenic differentiation. , 2012, Journal of Proteome Research.
[17] D R Mani,et al. iTRAQ Labeling is Superior to mTRAQ for Quantitative Global Proteomics and Phosphoproteomics* , 2011, Molecular & Cellular Proteomics.
[18] J. Chen,et al. An integrated proteomics analysis of bone tissues in response to mechanical stimulation , 2011, BMC Systems Biology.
[19] I. Jackson,et al. Loss of the BMP Antagonist, SMOC-1, Causes Ophthalmo-Acromelic (Waardenburg Anophthalmia) Syndrome in Humans and Mice , 2011, PLoS genetics.
[20] Ji‐Hyun Lee,et al. Phospho‐Smad1 modulation by nedd4 e3 ligase in BMP/TGF‐β signaling , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[21] M. Dadlez,et al. Proteomic characterization of biogenesis and functions of matrix vesicles released from mineralizing human osteoblast-like cells. , 2011, Journal of proteomics.
[22] T. Komori. Signaling networks in RUNX2‐dependent bone development , 2011, Journal of cellular biochemistry.
[23] X. Wang,et al. Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma , 2011, Cell & Bioscience.
[24] Y. Bae,et al. Secretome analysis of human BMSCs and identification of SMOC1 as an important ECM protein in osteoblast differentiation. , 2010, Journal of proteome research.
[25] J. Yates,et al. Role of PI3K on the regulation of BMP2-induced beta-Catenin activation in human bone marrow stem cells. , 2010, Bone.
[26] J. Yates,et al. 'Two-stage double-technique hybrid (TSDTH)' identification strategy for the analysis of BMP2-induced transdifferentiation of premyoblast C2C12 cells to osteoblast. , 2009, Journal of proteome research.
[27] D. Magne,et al. TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells. , 2009, Life sciences.
[28] J. Shaughnessy,et al. The role of Dickkopf-1 in bone development, homeostasis, and disease. , 2009, Blood.
[29] M. Kassem,et al. Osteoblastic cells: differentiation and trans-differentiation. , 2008, Archives of biochemistry and biophysics.
[30] Je-Yong Choi,et al. The Correlation of Salvia miltiorrhiza Extract–Induced Regulation of Osteoclastogenesis with the Amount of Components Tanshinone I, Tanshinone IIA, Cryptotanshinone, and Dihydrotanshinone , 2008 .
[31] John R Yates,et al. Cancer proteomics by quantitative shotgun proteomics , 2007, Molecular oncology.
[32] M. Ringuette,et al. Is SPARC an Evolutionarily Conserved Collagen Chaperone? , 2007, Journal of dental research.
[33] J. Caetano-Lopes,et al. Osteoblasts and bone formation. , 2007, Acta reumatologica portuguesa.
[34] K. Nagashima,et al. Analysis of the extracellular matrix vesicle proteome in mineralizing osteoblasts , 2007, Journal of cellular physiology.
[35] M. Lamghari,et al. Leptin effect on RANKL and OPG expression in MC3T3‐E1 osteoblasts , 2006, Journal of cellular biochemistry.
[36] Xu Cao,et al. BMP Signaling and Skeletogenesis , 2006, Annals of the New York Academy of Sciences.
[37] K. Cadigan,et al. Wnt signaling: complexity at the surface , 2006, Journal of Cell Science.
[38] Scott Vandenberg,et al. Comparing the protein expression profiles of human mesenchymal stem cells and human osteoblasts using gene ontologies. , 2005, Stem cells and development.
[39] Xizhi Guo,et al. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. , 2005, Developmental cell.
[40] S. Krane. Identifying genes that regulate bone remodeling as potential therapeutic targets , 2005, The Journal of experimental medicine.
[41] Di Chen,et al. Bone Morphogenetic Proteins , 2004, Growth factors.
[42] Henrik Birkedal,et al. Influence of the degradation of the organic matrix on the microscopic fracture behavior of trabecular bone. , 2004, Bone.
[43] David John Adams,et al. Regulation of Neuronal Voltage-gated Sodium Channels by the Ubiquitin-Protein Ligases Nedd4 and Nedd4-2* , 2004, Journal of Biological Chemistry.
[44] Ju-Hyun Kim,et al. RANKL regulates endothelial cell survival through the phosphatidylinositol 3′‐kinase/Akt signal transduction pathway , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[45] J. Lemonnier,et al. Activation of p38 Mitogen‐Activated Protein Kinase and c‐Jun‐NH2‐Terminal Kinase by BMP‐2 and Their Implication in the Stimulation of Osteoblastic Cell Differentiation , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[46] David L. Lacey,et al. Osteoclast differentiation and activation , 2003, Nature.
[47] Kenji Wakabayashi,et al. Proteome analysis of secreted proteins during osteoclast differentiation using two different methods: Two‐dimensional electrophoresis and isotope‐coded affinity tags analysis with two‐dimensional chromatography , 2003, Proteomics.
[48] A. Economides,et al. 0163-769X/03/$20.00/0 Endocrine Reviews 24(2):218–235 Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/er.2002-0023 Bone Morphogenetic Proteins, Their Antagonists, and the Skeleton , 2022 .
[49] Blagoy Blagoev,et al. A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling , 2003, Nature Biotechnology.
[50] Matthias Mann,et al. Mass spectrometric-based approaches in quantitative proteomics. , 2003, Methods.
[51] K. Wakabayashi,et al. PDGF BB purified from osteoclasts acts as osteoblastogenesis inhibitory factor (OBIF). , 2002, Journal of biomolecular techniques : JBT.
[52] N. Takahashi,et al. Regulatory mechanisms of osteoblast and osteoclast differentiation. , 2002, Oral diseases.
[53] G. Sukhikh,et al. Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.
[54] K. Wakabayashi,et al. Platelet‐Derived Growth Factor BB Secreted From Osteoclasts Acts as an Osteoblastogenesis Inhibitory Factor , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[55] E. Rofstad,et al. Transvascular and interstitial transport of a 19 kDa linear molecule in human melanoma xenografts measured by contrast‐enhanced magnetic resonance imaging , 2001, Journal of magnetic resonance imaging : JMRI.
[56] H. Nah,et al. The Roles of Annexins and Types II and X Collagen in Matrix Vesicle-mediated Mineralization of Growth Plate Cartilage* , 2000, The Journal of Biological Chemistry.
[57] S. Teitelbaum,et al. Bone resorption by osteoclasts. , 2000, Science.
[58] G. Karsenty,et al. The osteoblast: a sophisticated fibroblast under central surveillance. , 2000, Science.
[59] T. Martin,et al. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. , 1999, Endocrine reviews.
[60] N. Udagawa,et al. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. , 1999, Biochemical and biophysical research communications.
[61] J. Baum,et al. Folding of peptide models of collagen and misfolding in disease. , 1999, Current opinion in structural biology.
[62] D. Lacey,et al. Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.
[63] K Yano,et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[64] R. Dubose,et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function , 1997, Nature.
[65] G. Karsenty,et al. Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.
[66] L. N. Wu,et al. Association between proteoglycans and matrix vesicles in the extracellular matrix of growth plate cartilage. , 1991, The Journal of biological chemistry.
[67] Friedenstein Aj,et al. Origin of bone marrow stromal mechanocytes in radiochimeras and heterotopic transplants. , 1978 .
[68] G. Rho,et al. Multilineage potential and proteomic profiling of human dental stem cells derived from a single donor. , 2014, Experimental cell research.
[69] H. Deng,et al. Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. , 2013, Bone.
[70] R. Hájek,et al. Proteomic Analysis in Multiple Myeloma Research , 2011, Molecular biotechnology.
[71] M. Dadlez,et al. Proteome analysis of matrix vesicles isolated from femurs of chicken embryo , 2008, Proteomics.
[72] B. Riggs,et al. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. , 2000, Endocrinology.
[73] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[74] T. Yokozawa,et al. Confirmation that magnesium lithospermate B has a hydroxyl radical-scavenging action. , 1995, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[75] A. Friedenstein,et al. Origin of bone marrow stromal mechanocytes in radiochimeras and heterotopic transplants. , 1978, Experimental hematology.